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Abstract
It is well established that autoantibodies against desmoglein 3 and desmoglein 1 are relevant in the 
pathogenesis of pemphigus vulgaris and pemphigus foliaceus, including its endemic form, Fogo 
Selvagem (FS). Isolated reports have shown that in certain patients with these diseases, 
autoantibodies against other desmosomal cadherins and E-cadherin may also be present. The goal 
of this investigation was to determine if FS patients and normal individuals living in endemic 
areas possess autoantibodies against other desmosomal cadherins and E-cadherin. Testing a large 
number of FS and endemic control sera by ELISA we find a consistent and specific autoantibody 
response against desmoglein 1 and other keratinocyte cadherins in these individuals, which is 
quite different from US controls. Overall, the highest correlations among the autoantibody 
responses tested are in the endemic controls, followed by FS patients, and lowest in the US 
controls. These findings suggest that multiple, perhaps cross reactive, keratinocyte cadherins are 
recognized by FS patients and endemic controls.
Introduction
Both non-endemic pemphigus foliaceus (PF) and Fogo Selvagem (FS), show subcorneal 
epidermal blisters and pathogenic anti-desmoglein 1 (Dsg1) IgG autoantibodies (Beutner 
and Jordon, 1964; Beutner et al., 1968; Diaz et al., 1989a; Roscoe et al., 1985; Stanley et 
al., 1986a; Stanley et al., 1986b). FS patients usually live in rural areas of certain states of 
Brazil where the prevalence of disease is higher than in urban communities (Diaz et al., 
Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, 
subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
Corresponding author: Luis A. Diaz, M.D., Department of Dermatology, University of North Carolina at Chapel Hill, 410B Mary 
Ellen Jones Building, CB#7287, Chapel Hill, North Carolina 27599, USA. ldiaz@med.unc.edu Phone: 919-843-7226, Fax: 
919-8966-3898. 
Conflict of Interest
The authors state no conflict of interest.
HHS Public Access
Author manuscript
J Invest Dermatol. Author manuscript; available in PMC 2013 July 14.
Published in final edited form as:













1989b). The disease exhibits a strong association with the HLA-DRB1*0102, 0404 and 
1402 alleles (Moraes et al., 1997). It is thought that an environmental antigen(s) may trigger 
FS (Flores et al., 2009).
One of the relevant target antigens in both PF and FS is the desmosomal cadherin, Dsg1 
(Buxton et al., 1993; Stanley et al., 1986a). Desmosomal cadherins are transmembrane 
glycoproteins that are critical components of the desmosome, one of the keratinocyte 
intercellular junctions (Desai et al., 2009). They include the desmogleins (Dsg) and 
desmocollins (Dsc), each with well characterized isoforms; four of Dsg (Dsg1–4) and three 
of Dsc (Dsc1–3) (Thomason et al., 2010). Desmosomal cadherins are structurally and 
functionally similar to the classic E-cadherin, which is the molecular component of the 
adherens junction. Adherens junctions are structurally located in the interdesmosomal 
regions of the keratinocyte cell surface (Green et al., 2010).
IgG anti-desmosomal autoantibodies from PF and FS sera are routinely detected by indirect 
immunofluorescence (IF), which for decades have been utilized as a diagnostic test for these 
diseases. The application of ELISA techniques using recombinant human Dsg1 has 
improved diagnostic accuracy (Amagai et al., 1999) and made it possible to test large 
numbers of individuals living in communities where FS is endemic (Qaqish et al., 2009; 
Warren et al., 2003). ELISA studies have also identified IgG4 anti-Dsg1 autoantibodies as a 
serological predictor of FS (Qaqish et al., 2009; Warren et al., 2003). Moreover, anti-Dsg1 
autoantibodies of the IgM (Diaz et al., 2008) and IgE (Qian et al., 2011) class have also 
been detected in the sera of a large number of FS patients, suggesting an ongoing 
environmental trigger. While anti-Dsg1 IgG and IgG4 autoantibodies have been shown to be 
pathogenic in PF and FS (Rock et al., 1989), there have been reports of autoantibody 
responses to other members of the cadherin family of proteins in certain pemphigus 
phenotypes. Dsg3 is diagnostic and pathogenically relevant in pemphigus vulgaris (PV) 
(Amagai et al., 1991), while Dsc antigens may be relevant in IgA pemphigus (Duker et al., 
2009) and certain forms of PV (Mao et al., 2010). Autoantibodies against Dsg4 (Nagasaka et 
al., 2004) and E-cadherin (Evangelista et al., 2008) have also been described in PV and PF, 
respectively.
It is accepted that the desmosome, specifically its structural component Dsg1, is the target of 
pathogenic IgG4 polyclonal autoantibodies generated by FS patients. The IgG response in 
FS is complex and may result from exposure to environmental antigens and/or to self Dsg1. 
Moreover, the final pathogenic IgG4 response may evolve via phenomena such as 
crossreactivity with other desmosomal cadherins and/or epitope spreading. The aim of this 
study, therefore, was to determine the IgG autoantibody profile for each of the eight 
keratinocyte cadherins in a large number of subjects from three groups, i.e. FS patients, 
healthy individuals from US (US controls) and healthy individuals living in an endemic area 
of FS (endemic controls). We find that a substantial number of FS patients and endemic 
controls possess autoantibodies not only to Dsg1, but to other keratinocyte cadherins as well. 
Some of these autoantibody responses show strong correlations in the FS and endemic 
control groups.
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Index value distribution and comparison of 8 antigen/antibody systems in FS patients and 
two healthy control groups
Sera of 101 FS patients, 106 healthy controls from the US (US controls), and 106 healthy 
controls from endemic areas (endemic controls) were tested for the presence of IgG 
autoantibodies to Dsg1, Dsg2, Dsg3, Dsg4, Dsc1, Dsc2, Dsc3, and E-cadherin by ELISA. 
The distribution of index values for each antigen/antibody system is depicted in box plot 
format (Figure 1). Median index values are reported in Table 1. To evaluate for significant 
differences, the data was further analyzed using a 24 pairwise comparison (three groups of 
sera compared to each other for each of 8 antigen/antibody systems). A Bonferroni 
correction was used to adjust for multiple comparisons among 24 tests; thus, for an overall 
alpha of 0.05, only p values below 0.05/24=0.0021 are considered significant (Table 1).
As expected, we find higher anti-Dsg1 index values in FS patients than in US and endemic 
controls (median 108.79 vs. −22.83 and −9.26, respectively; p<0.0001). The differences are 
also significant when comparing index values of FS patients and US controls in 5 of the 7 
remaining antigen/antibody systems (Dsg4 and Dsc2 were not significant). Additionally, the 
differences between index values of FS patients and endemic controls are all significant, 
except for Dsc2 and E-cadherin responses (p=0.4033 and p=0.2524, respectively).
Comparison of index values of US controls and endemic controls reveals statistically 
significant differences for 4 antigen/antibody systems (Dsg3, Dsg4, Dsc3 and E-cadherin). 
There are 3 antigen/antibody systems where the endemic controls have higher index values 
than US controls, i.e. Dsg4 (median −15.59 vs. −47.28; <0.0001), Dsc3 (median −3.57 vs. 
−82.00; p<0.0001) and E-cadherin (median 44.67 vs. −47.47; p<0.0001), and 1 where the 
index values of US controls are higher than endemic controls, i.e. Dsg3 (median −3.78 vs. 
−75.16; <0.0001). The differences in index values for the remaining antigen/antibody 
systems were not significant (Dsg1 p=0.0162, Dsg2 p=0.0150, Dsc1 p=0.1119, and Dsc2 
p=0.802).
The receiver operator characteristic (ROC) of each of the eight antigen/antibody systems 
in FS patients and US controls
In order to define the relationships of specificity and sensitivity of each of the eight antigen/
antibody systems using the index values obtained in the FS patients and US controls we 
generated receiver operator characteristic (ROC) curves for each system (Figure 2). ROC 
curves were generated by plotting sensitivity against 1-specificity as the cutpoint is varied 
over the entire range of index values from a disease group (in this case FS patients) and a 
negative control group (US controls). The estimated area under the curve (AUC) is a 
summary of the entire ROC curve and is unaffected by choice of a cutpoint as is the case for 
sensitivity and specificity. The AUC is interpreted as the probability that a randomly 
selected patient will have a higher value than a randomly selected healthy control for the test 
in question. The three highest estimated AUCs are for Dsg1 (0.98, 95% CI: 0.96–1.0), Dsc3 
(0.90, CI: 0.85–0.94) and Dsc1 (0.88, CI: 0.84–0.93). It is noted that despite the high 
number of statistically significant differences found between FS patients and US controls as 
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depicted in Table 1, there is significant overlap in the distribution of index values in many of 
the antigen/antibody systems (Figure 1) which is reflected by low AUC values (Figure 2).
Percentage of serologically positive individuals in FS patients, endemic controls and US 
controls for each of the eight antigen/antibody systems tested
For each antigen/antibody system, we selected the cutpoint that would generate a specificity 
of 95%, i.e. false positive rate of 5% among US controls (Table 2). We defined all index 
values above the cutpoint as positive and then determined the percentage of FS patients and 
endemic controls testing positive for each antigen/antibody system (Figure 3). Figure 3 
shows the 5% false positive rate among US controls induced by the cutpoint selected. The 
FS patients show a high percentage (97%) of individuals with IgG reactivity to Dsg1. The 
FS patients also show a high percentage of individuals that test positive with each of the 
remaining 7 antigens (~ 40% for Dsg2, Dsg3, Dsc1 and ~50% for E-cadherin). Lower 
numbers of positive patients are found in the Dsg4 (~30%), Dsc2 (~20%) and Dsc3 (<20%) 
systems. A high percentage of endemic controls are also positive for the 8 antigens tested: ~ 
55% for E-cadherin, ~40% for Dsg1 and Dsc2, ~30% for Dsc1, ~28% for Dsg4 and ~ 20% 
for Dsg2. Lower percentages of positive individuals are detected in the Dsg3 (~14%) and 
Dsc3 (~12%).
The correlation of index values of the 8 antigen/antibody systems in FS patients and two 
healthy control groups
We next explored correlations among the responses to the 8 antigens within each group or 
population to determine whether a higher index value to Dsg1 would be predictive of a 
higher index value to any of the other antigens within a particular group. High correlations 
among the responses might suggest that the same pool of antibodies is responding to both 
antigens (crossreactivity) or that a common stimulus is inducing both responses to the same 
magnitude. To determine whether there was correlation among the index values of the 8 
antigen/antibody systems within each population, scatter plots were created by plotting 
index values for one antigen against index values for each of the remaining antigens. 
Spearman correlations were then computed (r value shown in the right lower quadrant of 
each panel). As shown in Figure 4a, Dsg1 index values in FS patients are highly correlated 
with the Dsc1 (r=0.77), Dsc3 (r=0.72) and Dsg4 (r=0.70) values. Thus, an FS patient with a 
high index value to Dsg1 tends to have a high index value to Dsc1, Dsc3, and Dsg4 as well. 
There are 28 pairwise correlations in each population of individuals. As a summary of these 
28 correlations, the average correlation and range were determined for each population of 
individuals. On average, the correlation among responses to the 8 antigens in the FS patients 
is 0.59 (range 0.40 – 0.88)(Figure 4a), but is lower in the US controls with an average of 
0.37 (range 0.03 – 0.74)(Figure 4b). In contrast, the correlations among responses to the 8 
antigens in the endemic controls are strikingly high with an average correlation of 0.79 
(range 0.55–0.97)(Figure 4c).
Discussion
This investigation was undertaken to assess the spectrum of autoantibody responses to 
keratinocyte cadherins in the serum of FS patients and control individuals from the US and 
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from a highly endemic area of FS in Brazil. The three unique groups tested include: (1) FS 
patients who are already showing the pathogenic autoantibody response, perhaps secondary 
to sensitization to an environmental antigen(s); (2) normal immunologically naïve 
individuals from a nonendemic area, (i.e. US group); and (3) individuals living in a Brazilian 
endemic region of FS, which may harbor the putative sensitizing antigen(s). This latter 
group may show autoantibody responses against keratinocyte cadherins that represent a 
transition between the previous two groups. A large number of FS and control sera were 
tested against the ectodomain of 7 desmosomal cadherins and E-cadherin by ELISA. The 
results show a consistent and specific autoantibody response against these cadherins in FS 
patients and endemic controls. Moreover, the autoantibody responses to some of these 
cadherin antigens are correlated.
Three observations can be drawn from this investigation:
a) The autoantibody response to the 8 antigens in FS patients, US controls, and endemic 
controls are unique and, in the majority of cases, significantly different in each of the three 
groups by 24 pairwise comparison of the 8 antigen/antibody systems. As expected, the index 
values of anti-Dsg1 autoantibodies from FS patients are significantly higher (p<0.0001) 
from US controls, producing an AUC of 0.98, CI (0.98–1.00). These findings confirm that 
the ELISA assay for anti-Dsg1 autoantibodies as reported by our group (Warren et al., 2000) 
and others (Amagai et al., 1999) is reliable, sensitive and specific, when used to distinguish 
FS patients and US controls.
Comparing the index values of the FS patients and the endemic controls we find that all 
index values are significantly different, with the exception of Dsc2 (p=0.4033) and E-
cadherin (p=0.2524). The lack of significant difference between the index values for Dsc2 
and E-cadherin in FS patients and endemic controls reflects extensive overlap in the 
distributions of index values in the two groups.
Comparison of index values between US controls and endemic controls reveals statistically 
significant differences for 4 antigen/antibody systems, Dsg3 (p<0.0001), Dsg4 (p<0.0001), 
Dsc3 (p<0.0001) and E-cadherin (p<0.0001). No significant differences are found for Dsg1 
(p=0.0162), Dsg2 (p=0.0150), Dsc1 (p=0.1119) and Dsc2 (p=0.820). A reasonable 
explanation for these differences (or lack of differences) remains unknown; however, an 
unsubstantiated speculation would be that the earliest response in donors from endemic 
areas may be mediated by autoantibodies against the first group of antigens (Dsg3, Dsg4, 
Dsc3 and E-cadherin).
b) As shown in Figure 2, ROCs of each antigen/antibody system provides a tool to evaluate 
the ability of each ELISA to separate known positive (FS patients) from known negative 
(US controls) individuals across a range of cutpoints. An AUC of 0.50 indicates that the test 
is no better than chance at detecting a positive case, whereas values closer to 1.0 indicate an 
optimal test. The AUCs of Dsg1 (0.98, CI: 0.98–1.00), Dsc1 (0.88, CI:0.84–0.930) and Dsc3 
(0.90, CI:0.85–0.95) show that these ELISAs are the best separators of FS patients from US 
controls. From our data, it is evident that aside from the Dsg1 ELISA, none of the remaining 
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7 antigen/antibody ELISA systems would useful as a diagnostic test for FS given their 
relatively low sensitivity.
ELISA cutpoints were chosen by setting a specificity of 95% to minimize false positives. 
Using these cutoffs (Figure 3), some FS patients have positive tests to Dsg1 (97%), Dsg2 
(42%), Dsg3 (41%), Dsc1 (43%), E-cadherin (50%), Dsg4 (29%), Dsc2 (24%) and Dsc3 
(16%). US controls show the 5% false positive rate determined by the selected specificity. 
Interestingly, endemic controls show a sizable number of positive individuals in some of the 
antigen/antibody systems, i.e. E-cadherin (56%), Dsg1 (42%), Dsc2 (41%), Dsg4 (32%), 
Dsc1 and (31%). These findings suggest the relevance of the environment surrounding the 
FS patients and the endemic controls as a source of sensitizing antigen(s) that lead to the 
production of these autoantibodies.
c) Finally, the Spearman correlations between antigen/antibody systems of the three groups 
show interesting results. First, there is low correlation between anti-Dsg1 autoantibodies and 
any of the seven remaining antigen/antibody systems in US controls. In contrast, anti-Dsg1 
autoantibodies show strong correlation with Dsc1 and Dsc3 antibodies in FS patients. FS 
patients exhibit a weaker correlation between anti-Dsg1 autoantibodies and Dsg4, Dsc2 and 
E-cadherin. Endemic controls show striking correlations between anti-Dsg1 autoantibodies 
with autoantibodies to Dsg3, Dsg4, Dsc1, Dsc2, Dsc3 and E-cadherin.
The strong correlations seen in endemic controls and FS patients suggest exposure of these 
individuals to a common environmental antigen(s). The antigen(s) may not be available in 
environments where US controls live. We acknowledge that it is difficult to distinguish 
between environmental and genetic influences on the autoantibody responses found in FS 
patients and endemic controls. Our current studies need further confirmation by establishing 
the autoantibody response of another control group composed of normal non-endemic 
Brazilian individuals of the same genetic stock as those of the LV endemic controls included 
in the current study. Should this new group generate results that do not overlap those of the 
endemic controls then the environmental etiology of FS would be strengthened.
There may be several explanations for these findings:
a. That the putative environmental antigen(s) may share cross-reactive epitopes with 
all the keratinocyte cadherins, thus triggering independent populations of 
autoantibodies with specificities to each of the 8 antigens;
b. That one or all of the environmentally-elicited anti-keratinocyte cadherin 
autoantibodies recognize crossreactive epitopes on the 8 antigens tested due to 
structural homologies among these keratinocyte cadherins;
c. Finally, it is feasible that once an initial autoantibody response is triggered against 
one of these cadherins (primary response), this response may be followed by 
autoantibody responses against other keratinocyte cadherins by the epitope 
spreading mechanism. However, as these results represent a single time point 
observation, determination of the progression of these responses over time (as seen 
in epitope spreading) is not possible with this data set.
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Since FS is a rare occurrence, it is likely that other factors such as the HLA may facilitate 
the development of this disease. It is intriguing that anti- E-cadherin autoantibodies are 
detected in a large number of individuals from the healthy endemic control (58%) and FS 
group (42%) raising the hypothesis that this primitive molecule may be the initial cross-
reactive antigen. Much work is needed to test these appealing speculations.
Materials and Methods
Sources of sera
A total of 313 sera from adult donors were tested for IgG autoantibodies against 7 
desmosomal cadherins and E-cadherin (101 sera were obtained from FS patients, 106 from 
healthy controls from the US, and 106 from healthy controls living in the Limao Verde 
endemic area of Brazil). FS sera were collected from patients originating from endemic 
regions, but hospitalized at the time of blood draw in three Brazilian hospitals dedicated to 
treat these patients: Hospital das Clinicas, Sao Paulo, (n= 25); Hospital de Doenças 
Tropicaes, Goiania, (n= 31), and Hospital Adventista do Penfigo, Campo Grande (n= 45). 
The disease was confirmed by clinical, histologic and immunofluorecent findings. The 
patients were in different clinical stages evolution and undergoing systemic steroid therapy. 
The indirect immunofluorescence studies showed anti-epidermal ICS autoantibodies in titers 
above 1:80 in ninety four patients, 1:40 in five, 1:20 in one case and negative in 1 case. 
Healthy control sera (defined as complete absence of cutaneous disease) were obtained from 
blood bank donors from the University of North Carolina Blood Bank and healthy 
individuals from Limao Verde, Brazil.
The study was approved by the University of North Carolina Institutional Review Board and 
conducted according to the Declaration of Helsinki Principles. Participants gave their 
written informed consent.
Construction and production of recombinant Dsg1, Dsg3 and E-cadherin antigens
We have previously constructed and expressed the entire extracellular domains of human 
Dsg1, Dsg3 and E-Cadherin using the baculovirus system (Diaz et al., 2008; Ding et al., 
1997; Ding et al., 1999). Soluble ectodomains of Dsg1, Dsg3 and E-cadherin were produced 
in High Five™ insect cells by infection with high titer recombinant baculovirus stocks. 
Optimal infection conditions for each recombinant protein were determined by time course 
studies (Liebman et al., 1999). The average protein yield was 10 ug/ml of culture 
supernatant.
Subcloning of Dsg2 ectodomain into a baculovirus expression vector
cDNA encoding the entire human Dsg2 was provided by Dr. M. Mahoney, Jefferson 
Medical School and used to construct the human Dsg2 ectodomain. The DNA of Dsg2 
ectodomain was amplified by PCR using primer pair of 5’-
ATCGGGCGCGGATCCATGGCGCGGAGCCCGGG-3’ and 5’-
ATTCGAAAGCGGCCGCCTAGTGATGGTGATGATGGTGCAGGCCCACATAGGAGT
CAT-3’ and was inserted into pFastBacI (Gibco Life Technologies, Gaithersburg, MD, 
USA) at BamHI and NotI sites. The coding region of the construct begins with the 
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endogenous initial Met followed by a putative signal sequence as well as an in-frame His-
tag at the C-terminal in order to ensure the secretion and to facilitate the purification and 
detection of the expressed antigen. The resulting plasmid, pFastBacI-Dsg2 ectodomain was 
used to construct into Bac-to-Bac system (Invitrogen, Carlsbad, CA, USA) following 
manufacturer’s protocol. Virus stock was prepared by infecting sf9 insect cell in Grace’s 
insect cell medium (Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine serum at 
27°C. Viral titers were determined by end point dilution assay in sf9.
Expression of Dsc1, Dsc2, and Dsc3 and Dsg4 recombinant antigens
The entire cDNA of the ectodomain of Dsc1, Dsc2, and Dsc3 constructed in the pEVmod 
were provided by Dr. Takashi Hashimoto, Dermatology, Kurume University, Japan. These 
cDNAs were subcloned into the BD BaculoGold virus vector (BD Biosciences, San Diego, 
CA, USA).
The Dsg4 extracellular domain already subcloned into baculovirus vector was kindly 
provided by Dr. Masayuki Amagai, Department of Dermatology, Keio University School of 
Medicine, Tokyo, Japan.
Production and purification of recombinant E-cadherin and desmosomal cadherins
His-tagged recombinant forms of Dsg1–4, Dsc1–3 and E-cadherin ectodomains were 
generated in the baculovirus expression system and purified by nickel affinity 
chromatography using the procedure previously described (Ding et al., 1997).
Enzyme-linked immunosorbent assay (ELISA)
Immunomicrotiter plates (Costar, Cambridge, MA, USA) were coated with one of the 8 
purified desmosomal cadherins (200 ng/well for Dsc1, Dsg1, Dsg3 and E-cadherin, 100ng/
well for Dsg2 and Dsc2 and 50ng/well for Dsg4 and Dsc3) at 4°C overnight. After washing 
5 times with Tris-buffered saline containing 5 mM Ca++ and 0.05% Tween-20 (TBS/Ca++/
T-20), the plate was blocked with 1% BSA in TBS/Ca++/T-20 at room temperature for 1 
hour. The plate was then washed 5 times and incubated with duplicate samples of diluted 
serum for 1 hour at room temperature. Following washes, the plate was incubated with 
diluted horseradish-peroxidase (HRP)-conjugated goat anti-human IgG (Bio-Rad, Hercules, 
CA, USA) for 1 hour (1:1000 for 7 desmosomal antigens and 1:1500 for E-cadherin). The 
color development was achieved with the peroxidase substrate o-phenylenediamine.
A FS serum (1:100 dilution) which produced consistent and reproducible positive OD values 
for IgG anti-Dsg1 autoantibodies was selected as a positive control. We also selected a 
positive serum (1:100 dilution) for Dsg2 (CG14), Dsg3 (Dip), Dsg4 (CG42a), Dsc1, Dsc2 
and Dsc3 (CG42a) and E-cadherin (1:200 dilution). A normal human serum from US was 
used as a negative control throughout. Results were expressed as index value units as 
reported by (Amagai et al., 1999) and (Diaz et al., 2008). The index value was defined in 
terms of OD as follows:
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Negative index values occur when the test sample OD is less than the negative control OD.
As a reference, we provide the average ODs of duplicate tests of negative and positive 
control sera used to generate index values: Dsg1 (negative 0.81, positive 1.60), Dsg2 
(negative 0.48, positive 1.92, Dsg3 (negative 1.39, positive 2.55), Dsg4 (negative 0.78, 
positive 2.45), Dsc1 (1.76, positive 3.16), Dsc2 (negative 1.65, positive 3.25), Dsc3 
(negative 0.68, positive 2.70), and E-cadherin (negative 0.17, positive 1.36).
Statistical analysis
Nonparametric methods (DeLong et al., 1988) were used estimation and testing of receiver 
operator characteristic (ROC) curves (Hanley and McNeil, 1982) and area under the curve 
(AUC). Spearman correlation was used to assess strength of correlation among the various 
measures. The R software (Team, 2011), version 2.13.0, was used to generate the graphs. 
The data analysis was done using SAS software. Copyright, SAS Institute Inc. SAS and all 
other SAS Institute Inc. product or service names are registered trademarks or trademarks of 
SAS Institute Inc., Cary, NC, USA.
The Wilcoxon rank sum test (Hollander and Wolfe, 1999) is a statistical hypothesis test of 
equality of two distributions (the distributions in the two groups). Briefly, the test is 
performed by pooling the two samples into one sample of n observations, ranking the values 
from smallest (rank=1) to largest (rank=n), computing the mean rank in each group, then 
comparing the mean ranks in a formal statistical fashion. It is somewhat similar in spirit to 
the 2-sample t-test, but it only takes the ordering of the observations into account, not their 
actual magnitude. Assumption of normal distributions is not required.
Adjustment for multiple comparisons controls the overall type-I error when a large number 
of hypothesis tests is made. For example, when 20 hypothesis tests are performed at the 0.05 
level each, and all 20 null hypotheses are in fact true, on average one test turns out 
statistically significant (p < 0.05), and the probability of one or more significant tests is 
larger than 0.05, and can be much larger. In fact, if the 20 tests are independent, there is a 
64% chance of at least one test showing a significant result when all 20 null hypotheses are 
true. Controlling the overall Type I error guarantees that the probability of one or more 
significant findings (p < 0.05), when all 20 null hypotheses are in fact true, is 0.05 or less. 
The Bonferroni method achieves that control by performing each test at the 0.05/20=0.0025 
level, i.e the overall Type-I error is divided by the number of tests. The method does not 
require the tests to be independent (Farcomeni, 2008).
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The distribution of index values among US controls, FS patients, and endemic controls. 
Dsg1 ELISA index values show the greatest separation of FS patients from both sets of 
controls (p<0.0001), but show no difference between the control groups (p=0.0162). Each 
box extends from the lower to the upper quartile (25–75%) with the median shown as a thick 
line within the box. The whiskers extend away from the box to the most extreme data point, 
which is no more than 1.5 times the length of the box. Data points beyond the whiskers are 
individually marked.
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Receiver operator characteristic curves (ROC curves) generated from US controls and FS 
patient data. The ROC curve is a scatter plot of sensitivity against 1-specificity as the 
cutpoint is varied over the entire range of index values. The area under the curves (AUCs) 
generated from these curves are shown in the right lower quadrant of each ROC box. The 
AUCs show that the highest performing antigen/antibody systems are Dsg1 (0.098), Dsc1 
(0.88), and Dsc3 (0.90).
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Percentage of serologically positive individuals among FS patients, endemic controls, and 
US controls for each of the eight antigen/antibody systems. This bar graph represents 
positive sera as defined by the cutpoint. FS patients (black bars), endemic controls (grey 
bars), and US controls (white bars) are shown.
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Correlation among the antibody responses. (a) FS patients, (b) US controls, and (c) endemic 
controls antibody response correlations are depicted by index value scatter plots for each 
antigen/antibody system against the others. The Spearman correlation coefficient (r value) 
for each scatter plot is listed in the bottom right corner of each plot. Average r values for 
each antigen/antibody system against the remaining 7 antigen/antibody systems are listed in 
the bottom right corner for each antigen. **=p<0.01, *= p<0.05, adjusting for multiple 
comparisons involving 84 p-values.
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Table 2
Index value cutpoints selected for the 8 antigen/antibody systems
Antigen Cutpoint1 Sensitivity Specificity
Dsg1 5 96% 95%
Dsg2 1.2 43% 95%
Dsg3 5 41% 95%
Dsg4 0.54 29% 95%
Dsc1 4 42% 95%
Dsc2 10 23% 95%
Dsc3 25 15% 95%
E-cadherin 40 49% 95%
1
Cutpoints were generated by selecting a set specificity of 95%.
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